Published in Biochim Biophys Acta on February 23, 1994
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother (1994) 1.95
Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg (2007) 1.85
The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J (1998) 1.61
Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer (2008) 1.53
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current. Antimicrob Agents Chemother (2008) 1.17
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer (2001) 1.03
Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer (2002) 1.01
Electrochemotherapy on liver tumours in rabbits. Br J Cancer (1998) 0.99
Bioelectric effect and bacterial biofilms. A systematic review. Int J Artif Organs (2008) 0.97
First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer (1997) 0.96
Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice. BMC Cancer (2005) 0.90
A three-dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation. Biophys J (2012) 0.88
Increased doxorubicin uptake and toxicity in multicellular tumour spheroids treated with DC electrical fields. Br J Cancer (1999) 0.78
The controversial role of electrochemotherapy in head and neck cancer: a systematic review of the literature. Eur Arch Otorhinolaryngol (2017) 0.75
Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells. J Cell Biol (1998) 2.92
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer (1991) 2.79
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Case for active physician involvement in US practice. Radiology (1996) 2.02
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol (1988) 1.91
Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer (1993) 1.90
A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta (2000) 1.83
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res (1993) 1.74
Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta (1993) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
[Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III (1991) 1.52
Fast kinetics of calcium release induced by myo-inositol trisphosphate in permeabilized rat hepatocytes. J Biol Chem (1989) 1.48
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther (2008) 1.39
Bleomycin: revival of an old drug. Gen Pharmacol (1996) 1.39
DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther (2004) 1.37
Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol (1991) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med (2004) 1.31
Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer (1996) 1.30
Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs (1998) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer (1991) 1.26
In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta (1999) 1.24
Detergent structure and associated lipid as determinants in the stabilization of solubilized Ca2+-ATPase from sarcoplasmic reticulum. J Biol Chem (1989) 1.22
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw (1992) 1.15
Cranio-orbito-zygomatic measurements from standard CT scans in unoperated Crouzon and Apert infants: comparison with normal controls. Cleft Palate Craniofac J (1992) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy. Bioelectrochemistry (2002) 1.11
Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol (1999) 1.10
Screening for oropharyngeal dysphagia in stroke: insufficient evidence for guidelines. Dysphagia (2000) 1.10
Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol (1995) 1.10
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J (1996) 1.10
Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med (2004) 1.09
A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun (1993) 1.09
Effects of phospholipids on binding of calcium to (Ca2(+)-Mg2(+)-ATPase. Biochemistry (1990) 1.08
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta (2000) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Mechanism of inhibition of the (Ca2(+)-Mg2+)-ATPase by nonylphenol. Biochemistry (1990) 1.06
The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer (2001) 1.06
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Eur J Biochem (1997) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun (1993) 1.04
Role of pulse shape in cell membrane electropermeabilization. Biochim Biophys Acta (2003) 1.04
Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem J (1998) 1.03
Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis. Exp Cell Res (1995) 1.03
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part I. Increased efficiency of permeabilization. Bioelectrochemistry (2001) 1.01
A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat (2007) 1.01
Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther (2008) 1.00
Electrochemotherapy in veterinary oncology. J Vet Intern Med (2008) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Electrochemotherapy on liver tumours in rabbits. Br J Cancer (1998) 0.99
Membrane solubilization by detergent: use of brominated phospholipids to evaluate the detergent-induced changes in Ca2+-ATPase/lipid interaction. Biochemistry (1989) 0.99
Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun (1999) 0.98
Fluoroscopically-guided manipulation of malfunctioning peritoneal dialysis catheters. Perit Dial Int (2000) 0.97
ATP regulation of sarcoplasmic reticulum Ca2+-ATPase. Metal-free ATP and 8-bromo-ATP bind with high affinity to the catalytic site of phosphorylated ATPase and accelerate dephosphorylation. J Biol Chem (1988) 0.97
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol (1994) 0.96
First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer (1997) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Blood (2001) 0.94
Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol (1998) 0.94
Facial sensibility in adolescents with and without clefts 1 year after undergoing Le Fort I osteotomy. Plast Reconstr Surg (1994) 0.93
Cell membrane electropermeabilization by symmetrical bipolar rectangular pulses. Part II. Reduced electrolytic contamination. Bioelectrochemistry (2001) 0.93
Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles. Biochem Biophys Res Commun (1993) 0.92
Highly efficient oligonucleotide transfer into intact yeast cells using square-wave pulse electroporation. Biotechniques (1998) 0.92
Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cells. Biochem Biophys Res Commun (1989) 0.88
Evaluation of cell membrane electropermeabilization by means of a nonpermeant cytotoxic agent. Biotechniques (2000) 0.87
Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model. Cancer Res (1993) 0.87
In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer (2003) 0.87
Inhibition of tumor growth by histoincompatible cells expressing interleukin-2. Int Immunol (1992) 0.87
The metal sites on sarcoplasmic reticulum membranes that bind lanthanide ions with the highest affinity are not the ATPase Ca2+ transport sites. J Biol Chem (1992) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities. Cancer Biochem Biophys (1998) 0.86
Molecular signature of the immune and tissue response to non-coding plasmid DNA in skeletal muscle after electrotransfer. Gene Ther (2011) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Efficient DNA electrotransfer into tumors. Bioelectrochemistry (2000) 0.84
Search for dilepton resonances in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2011) 0.83
Measurement of the CP asymmetry amplitude sin2beta with B0 mesons. Phys Rev Lett (2002) 0.83
Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs. Curr Drug Metab (2009) 0.83
Observation of the semileptonic decays B-->D*tau-nutau and evidence for B-->Dtau-nutau. Phys Rev Lett (2008) 0.83
Search for scalar bottom quark pair production with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.82